Alternatively, monocytic EPCs recruited to the SSc-affected sites could be a source of soluble factors, such as MCP-1, platelet-derived growth factor, and interleukin-6, all of which accelerate fibrosis. Here, CCL2 is linked to systemic sclerosis.